PCI Biotech is a biopharmaceutical company focusing on development and commercialisation of novel therapies for the treatment of cancer through its innovative photochemical internalisation (PCI) technology platform.  PCI is applied to three distinct anticancer paradigms: fimaCHEM (enhancement of chemotherapeutics for localised treatment of cancer), fimaVACC (T-cell induction technology for therapeutic vaccination), and fimaNAC (nucleic acid therapeutics delivery).


Biotechnology

PCI Biotech

Kristin Eivindvik

Ronny Skuggedal

Anders Høgset

The executive team at PCI Biotech has experience in various medical and healthcare fields. The team includes a VP of Business Operations, a Project Director, and an Associate-Director. All three members have experience working in similar positions at other companies, including Alertis Medical, GE Healthcare, and Nycomed Imaging / Amersham Health / GE Healthcare. They also all have education histories from the University of Oslo in Inst. of Pharmacy.

CEO and Executive Team

About

Team members

Other teams at PCI Biotech

Leadership Team

Board of Directors